# Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer

> **NCT04600518** · — · COMPLETED · sponsor: **Novomics. Co., Ltd.** · enrollment: 2047 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DEVICE:** nProfiler I Stomach Cancer Assay Kit

## Key facts

- **NCT ID:** NCT04600518
- **Lead sponsor:** Novomics. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-07
- **Primary completion:** 2023-06-18
- **Final completion:** 2023-06-22
- **Target enrollment:** 2047 (ACTUAL)
- **Last updated:** 2024-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04600518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04600518, "Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04600518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*